Northwestern Medicine investigators have uncovered new insights into how metabolic dysfunction contributes to Parkinson's ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

By 2050, there will be 25.2 million people living with Parkinson's disease worldwide (a 112% increase from 2021), largely due ...

Communities across Blackpool are being invited to apply for a new grants programme for 2025 which is helping more people to ...

As global populations age, neurological disorders such as Alzheimer's, Parkinson's, and epilepsy become more prevalent.

Kirsten Ostherr asks, 'What if we engaged with our health care narratives with the same fervor we bring to refreshing our ...

By 2050, there will be 25.2 million people living with Parkinson’s disease worldwide (a 112% increase from 2021), largely due to population ageing, suggests a modelling study published by The ...

Prevalence rates of what GSK calls "deviant" sexual behaviours caused by the drugs are unknown and tend to be under-reported ...

Groundbreaking research that has led to the development of a wrist device to help control tics in people with Tourette ...

Parkinson’s UK is supporting the launch of a new database of approved Parkinson’s personal trainers and exercise coaches ...

Registrations are now being accepted for the University of Wyoming Center on Aging’s (WyCOA) free educational opportunities for individuals living with Parkinson’s disease, care partners, families and ...

A new study led by researchers at researchers at Baylor College of Medicine, AstraZeneca and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital reveals a breakthrough ...